« Previous
Next »
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 2
, Pages 91-95
, March 2011
Effect of steroid, carbogen inhalation, and lipoprostaglandin E1 combination therapy for sudden sensorineural hearing loss
References
- . Effect of carbogen inhalation on peripheral tissue perfusion and oxygenation in patients suffering from sudden hearing loss. Ann Otol Rhinol Laryngol. 1999;108:944–947
- . Management of sudden deafness. Otolaryngol Head Neck Surg. 1983;91:3–8
- . Perilymph oxygenation in sudden and progressive sensorineural hearing loss. Acta Otolaryngol. 1983;96:57–68
- . Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss. Am J Otolaryngol. 2005;26:245–248
- . Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells. Acta Anaesthesiol Scand. 2002;46:987–993
- . Effects of adjuvant PGE1 therapy following profundaplasty in patients with severe limb ischaemia early and long-term results. Vasa. 1997;26:117–121
- Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. Lancet. 1990;335:627–628
- . A hypothesis on the consolidation and PGE1-induced deconsolidation of a platelet plug. Platelets. 2003;14:463–471
- . The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am. 1975;8:467–473
- . Viral and epidermiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg. 1983;91:653–658
- . Management of idiopathic sudden sensorineural hearing loss. Am J Otol. 1999;20:587–595
- Sudden deafness: a comparison of anticoagulant therapy and carbogen inhalation therapy. Ann Otol Laryngol. 1997;106:22–26
- . Intratympanic steroid treatment: a review. Otol Neurotol. 2004;25:1034–1039
- . Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22:18–23
- Sudden sensorineural hearing loss, does application of glucocorticoids make sense?. Arch Otolaryngol Head Neck Surg. 2001;127:253–258
- . Treatment of vasospastic disease with prostaglandin E1. Br Med J. 1980;281:1031–1034
- . Effects of intravenous administration of prostaglandin E1 and lipo-prostaglandin E1 on cochlear blood flow in guinea pigs. Eur Arch Otorhinolarygol. 2002;259:253–256
- . Cyclic AMP and mechanism of vasodilation. Pharmacol Ther. 1990;47:329–345
- . An hypothesis on the consolidation and PGE1-induced deconsolidation of a platelet plug. Platelets. 2003;14:463–471
- . Evaluation of prostaglandin E1 therapy for sudden deafness. Laryngoscope. 1989;99:542–546
- Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otol Neurotol. 2002;23:665–668
- . Idiopathic sudden sensorineural hearing loss. Am J Otol. 1989;10:242–247
- . Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86:463–480
PII: S0196-0709(09)00249-X
doi: 10.1016/j.amjoto.2009.10.004
© 2011 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 2
, Pages 91-95
, March 2011
